Proglin

Proglin

vildagliptin

Manufacturer:

UNILAB, Inc

Distributor:

UNILAB, Inc
Concise Prescribing Info
Contents
Vildagliptin
Indications/Uses
Treatment of type 2 DM as monotherapy; in dual combination w/ metformin, sulfonylurea or thiazolidinedione (TZD).
Dosage/Direction for Use
Monotherapy, combination therapy w/ metformin, TZD or insulin (w/ or w/o metformin) 50 or 100 mg daily. Dual combination w/ sulfonylurea 50 mg once daily. Triple combination w/ metformin & sulfonylurea 100 mg once daily. 50-mg dose Administer once daily in the morning. 100-mg dose Administer as 2 divided doses of 50 mg given in the morning & evening.
Administration
May be taken with or without food.
Contraindications
Special Precautions
Patients w/ type 1 diabetes or for the treatment of diabetic ketoacidosis; patients w/ hepatic impairment, pre-treatment ALT or AST >2.5 x the upper limit of normal, NYHA class III. Pregnancy & lactation. Childn <18 yr.
Adverse Reactions
Dizziness, headache, constipation, peripheral edema, hepatitis, urticaria, bullous & exfoliative skin lesions, including bullous pemphigoid, pancreatitis, arthralgia (sometimes severe).
MIMS Class
Antidiabetic Agents
ATC Classification
A10BH02 - vildagliptin ; Belongs to the class of dipeptidyl peptidase 4 (DPP-4) inhibitors. Used in the treatment of diabetes.
Presentation/Packing
Form
Proglin tab 50 mg
Packing/Price
28's (P764/box)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in